Neomed Innovation V L.p. - Net Worth and Insider Trading

Neomed Innovation V L.p. Net Worth

The estimated net worth of Neomed Innovation V L.p. is at least $299,335 dollars as of 2024-11-13. Neomed Innovation V L.p. is the 10% Owner of X4 Pharmaceuticals Inc and owns about 867,639 shares of X4 Pharmaceuticals Inc (XFOR) stock worth over $299,335. Details can be seen in Neomed Innovation V L.p.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Neomed Innovation V L.p. has not made any transactions after 2017-11-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Neomed Innovation V L.p.

To

Neomed Innovation V L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Neomed Innovation V L.p. owns 2 companies in total, including Axonics Inc (AXNX) , and X4 Pharmaceuticals Inc (XFOR) .

Click here to see the complete history of Neomed Innovation V L.p.’s form 4 insider trades.

Insider Ownership Summary of Neomed Innovation V L.p.

Ticker Comapny Transaction Date Type of Owner
AXNX Axonics Inc 2018-10-30 10 percent owner
XFOR X4 Pharmaceuticals Inc 2017-11-20 10 percent owner

Neomed Innovation V L.p. Latest Holdings Summary

Neomed Innovation V L.p. currently owns a total of 1 stock. Neomed Innovation V L.p. owns 867,639 shares of X4 Pharmaceuticals Inc (XFOR) as of November 20, 2017, with a value of $299,335.

Latest Holdings of Neomed Innovation V L.p.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
XFOR X4 Pharmaceuticals Inc 2017-11-20 867,639 0.35 299,335

Holding Weightings of Neomed Innovation V L.p.


Neomed Innovation V L.p. Form 4 Trading Tracker

According to the SEC Form 4 filings, Neomed Innovation V L.p. has made a total of 0 transactions in X4 Pharmaceuticals Inc (XFOR) over the past 5 years. The most-recent trade in X4 Pharmaceuticals Inc is the acquisition of 300,000 shares on November 20, 2017, which cost Neomed Innovation V L.p. around $3 Million.

Insider Trading History of Neomed Innovation V L.p.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Neomed Innovation V L.p. Trading Performance

GuruFocus tracks the stock performance after each of Neomed Innovation V L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Neomed Innovation V L.p. is 0.28%. GuruFocus also compares Neomed Innovation V L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Neomed Innovation V L.p. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Neomed Innovation V L.p.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Neomed Innovation V L.p.

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -13.97 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -17.73 LIMIT LIMIT LIMIT LIMIT LIMIT

Neomed Innovation V L.p. Ownership Network

Ownership Network List of Neomed Innovation V L.p.

No Data

Ownership Network Relation of Neomed Innovation V L.p.

Insider Network Chart

Neomed Innovation V L.p. Owned Company Details

What does Axonics Inc do?

Who are the key executives at Axonics Inc?

Neomed Innovation V L.p. is the 10 percent owner of Axonics Inc. Other key executives at Axonics Inc include Chief Financial Officer Kari Leigh Keese , Chief Medical Officer Karen Noblett , and director & Chief Executive Officer Raymond W Cohen .

Axonics Inc (AXNX) Insider Trades Summary

Over the past 18 months, Neomed Innovation V L.p. made no insider transaction in Axonics Inc (AXNX). Other recent insider transactions involving Axonics Inc (AXNX) include a net sale of 35,287 shares made by Karen Noblett , a net sale of 32,884 shares made by Ford Alfred J Jr , and a net sale of 15,674 shares made by Danny L. Dearen .

In summary, during the past 3 months, insiders sold 2,961 shares of Axonics Inc (AXNX) in total and bought 0 shares, with a net sale of 2,961 shares. During the past 18 months, 141,355 shares of Axonics Inc (AXNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 141,355 shares.

Axonics Inc (AXNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Axonics Inc Insider Transactions

No Available Data

Neomed Innovation V L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Neomed Innovation V L.p.. You might contact Neomed Innovation V L.p. via mailing address: 13, Castle Street, St. Helier Y9 Je4 5ut.